BROMOCRIPTINE MESYLATE

Bromocriptine Mesylate Adverse Events Reported to the FDA Over Time

How are Bromocriptine Mesylate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Bromocriptine Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Bromocriptine Mesylate is flagged as the suspect drug causing the adverse event.

Most Common Bromocriptine Mesylate Adverse Events Reported to the FDA

What are the most common Bromocriptine Mesylate adverse events reported to the FDA?

Drug Exposure During Pregnancy	30 (2.58%)
Hallucination, Visual	21 (1.81%)
Vomiting	18 (1.55%)
Muscle Rigidity	17 (1.46%)
Nausea	17 (1.46%)
Impulse-control Disorder	15 (1.29%)
Headache	14 (1.2%)
Dyspnoea	13 (1.12%)
Persecutory Delusion	13 (1.12%)
Pyrexia	13 (1.12%)
Hypersexuality	12 (1.03%)
	Show More
Blood Prolactin Increased	11 (.95%)
Apathy	10 (.86%)
Heart Rate Increased	10 (.86%)
Condition Aggravated	9 (.77%)
Drug Ineffective	9 (.77%)
Drug Interaction	9 (.77%)
Neuroleptic Malignant Syndrome	9 (.77%)
Premature Baby	9 (.77%)
Abdominal Pain	8 (.69%)
Blood Creatine Phosphokinase Increa...	8 (.69%)
Foetal Heart Rate Abnormal	8 (.69%)
Premature Labour	8 (.69%)
Abdominal Tenderness	7 (.6%)
Abnormal Behaviour	7 (.6%)
Akinesia	7 (.6%)
Caesarean Section	7 (.6%)
Dyskinesia	7 (.6%)
Ectopic Pregnancy	7 (.6%)
Laparotomy	7 (.6%)
Peritoneal Haemorrhage	7 (.6%)
Psychotic Disorder	7 (.6%)
Salpingectomy	7 (.6%)
Visual Field Defect	7 (.6%)
Abdominal Distension	6 (.52%)
Abdominal Rigidity	6 (.52%)
Affect Lability	6 (.52%)
Autonomic Nervous System Imbalance	6 (.52%)
Blood Pressure Systolic Decreased	6 (.52%)
Breast Engorgement	6 (.52%)
Cardiac Failure	6 (.52%)
Chest Discomfort	6 (.52%)
Communication Disorder	6 (.52%)
Dehydration	6 (.52%)
Fallopian Tube Perforation	6 (.52%)
Heterotopic Pregnancy	6 (.52%)
Hypertension	6 (.52%)
Loss Of Consciousness	6 (.52%)
Normal Newborn	6 (.52%)
Pathological Gambling	6 (.52%)
Shock	6 (.52%)
Somnolence	6 (.52%)
Stress Cardiomyopathy	6 (.52%)
Suicide Attempt	6 (.52%)
Trigeminal Neuralgia	6 (.52%)
Urinary Tract Infection	6 (.52%)
Uterine Cervical Pain	6 (.52%)
Aggression	5 (.43%)
Agitation	5 (.43%)
Arteriospasm Coronary	5 (.43%)
Blood Lactate Dehydrogenase Increas...	5 (.43%)
Blood Pressure Increased	5 (.43%)
Constipation	5 (.43%)
Death	5 (.43%)
Depression	5 (.43%)
Fall	5 (.43%)
Hyperhidrosis	5 (.43%)
Hyperthermia	5 (.43%)
Malaise	5 (.43%)
Muscle Atrophy	5 (.43%)
Obsessive-compulsive Disorder	5 (.43%)
Oedema Peripheral	5 (.43%)
Peripartum Cardiomyopathy	5 (.43%)
Pituitary Tumour	5 (.43%)
Activities Of Daily Living Impaired	4 (.34%)
Alanine Aminotransferase Increased	4 (.34%)
Angiopathy	4 (.34%)
Aspartate Aminotransferase Increase...	4 (.34%)
Breast Pain	4 (.34%)
Consciousness Fluctuating	4 (.34%)
Dizziness	4 (.34%)
Drug Level Increased	4 (.34%)
Dyspnoea Paroxysmal Nocturnal	4 (.34%)
Ejection Fraction Decreased	4 (.34%)
General Physical Health Deteriorati...	4 (.34%)
Hemianopia	4 (.34%)
Hyperprolactinaemia	4 (.34%)
Lactation Disorder	4 (.34%)
Leukocytosis	4 (.34%)
Mastitis	4 (.34%)
Metabolic Acidosis	4 (.34%)
Mucosal Dryness	4 (.34%)
Orthopnoea	4 (.34%)
Orthostatic Hypotension	4 (.34%)
Pituitary Haemorrhage	4 (.34%)
Psychomotor Hyperactivity	4 (.34%)
Renal Failure Acute	4 (.34%)
Sinus Tachycardia	4 (.34%)
Surgery	4 (.34%)
Ventricular Fibrillation	4 (.34%)
Weight Decreased	4 (.34%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Bromocriptine Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Bromocriptine Mesylate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Bromocriptine Mesylate

What are the most common Bromocriptine Mesylate adverse events reported to the FDA?

Gastrointestinal Signs	64 (5.51%)
Neurological	48 (4.13%)
Disturbances In Thinking	38 (3.27%)
Chemical Injury And Poisoning	34 (2.93%)
Cardiac And Vascular Investigations	31 (2.67%)
Movement Disorders	28 (2.41%)
Therapeutic And Nontherapeutic Effe...	25 (2.15%)
Muscle	24 (2.07%)
Endocrine Investigations	22 (1.89%)
Respiratory	22 (1.89%)
Breast	21 (1.81%)
	Show More
Cardiac Arrhythmias	21 (1.81%)
Impulse Control	21 (1.81%)
Maternal Complications Of Pregnancy	20 (1.72%)
Body Temperature Conditions	18 (1.55%)
Coronary Artery	18 (1.55%)
Mood Disorders	18 (1.55%)
Hypothalamus And Pituitary Gland	17 (1.46%)
Obstetric And Gynecological Therape...	17 (1.46%)
Injuries	16 (1.38%)
Neuromuscular	16 (1.38%)
Headaches	15 (1.29%)
Neurological Disorders Of The Eye	14 (1.2%)
Sexual Dysfunctions, Disturbances A...	14 (1.2%)
Anxiety Disorders	13 (1.12%)
Decreased And Nonspecific Blood Pre...	13 (1.12%)
Enzyme	13 (1.12%)
Myocardial	13 (1.12%)
Pregnancy, Labour, Delivery And Pos...	13 (1.12%)
Infections - Pathogen Unspecified	12 (1.03%)
Lifestyle Issues	12 (1.03%)
Central Nervous System Vascular	11 (.95%)
Neonatal And Perinatal Conditions	11 (.95%)
Physical Examination Topics	11 (.95%)
Therapeutic Procedures And Supporti...	10 (.86%)
Abortions And Stillbirth	9 (.77%)
Cardiac Valve	9 (.77%)
Fetal And Neonatal	9 (.77%)
Hematology Investigations	9 (.77%)
Hepatobiliary	9 (.77%)
Procedural And Device Related Injur...	9 (.77%)
Schizophrenia And Other Psychotic	9 (.77%)
Depressed Mood Disorders	8 (.69%)
Maternal Complications Of Labour An...	8 (.69%)
Peritoneal And Retroperitoneal Cond...	8 (.69%)
Personality Disorders	8 (.69%)
Renal Disorders	8 (.69%)
Seizures	8 (.69%)
Bone Disorders	7 (.6%)
Electrolyte And Fluid Balance Condi...	7 (.6%)
Gastrointestinal Therapeutic Proced...	7 (.6%)
Medication Errors	7 (.6%)
Psychiatric	7 (.6%)
Psychiatric And Behavioural Symptom...	7 (.6%)
Renal And Urinary Tract Investigati...	7 (.6%)
Vascular Hypertensive	7 (.6%)
Cervix Disorders	6 (.52%)
Communication Disorders	6 (.52%)
Cranial Nerve Disorders	6 (.52%)
Epidermal And Dermal Conditions	6 (.52%)
Heart Failures	6 (.52%)
Metabolic, Nutritional And Blood Ga...	6 (.52%)
Suicidal And Self-injurious Behavio...	6 (.52%)
Urinary Tract Signs	6 (.52%)
Vascular	6 (.52%)
Vision	6 (.52%)
Arteriosclerosis, Stenosis, Vascula...	5 (.43%)
Endocrine Neoplasms Malignant And U...	5 (.43%)
Fatal Outcomes	5 (.43%)
Gastrointestinal Motility And Defec...	5 (.43%)
Menstrual Cycle And Uterine Bleedin...	5 (.43%)
Skin Appendage Conditions	5 (.43%)
Acid-base	4 (.34%)
Bacterial Infectious	4 (.34%)
Bone And Joint Injuries	4 (.34%)
Endocrine Gland Therapeutic Procedu...	4 (.34%)
Hepatic And Hepatobiliary	4 (.34%)
Investigations, Imaging And Histopa...	4 (.34%)
Lower Respiratory Tract Disorders	4 (.34%)
Ovarian And Fallopian Tube	4 (.34%)
Toxicology And Therapeutic Drug Mon...	4 (.34%)
White Blood Cell	4 (.34%)
Allergic Conditions	3 (.26%)
Cardiac Disorder Signs	3 (.26%)
Deliria	3 (.26%)
Gender Related Factors	3 (.26%)
Glucose Metabolism Disorders	3 (.26%)
Increased Intracranial Pressure And...	3 (.26%)
Musculoskeletal And Connective Tiss...	3 (.26%)
Neoplasm Related Morbidities	3 (.26%)
Nervous System, Skull And Spine The...	3 (.26%)
Neurological, Special Senses And Ps...	3 (.26%)
Pericardial	3 (.26%)
Peripheral Neuropathies	3 (.26%)
Reproductive Neoplasms Female Malig...	3 (.26%)
Appetite And General Nutritional	2 (.17%)
Breast Neoplasms Benign	2 (.17%)
Cardiac And Vascular Disorders Cong...	2 (.17%)
Embolism And Thrombosis	2 (.17%)
Legal Issues	2 (.17%)
Manic And Bipolar Mood Disorders	2 (.17%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Bromocriptine Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Bromocriptine Mesylate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.